肌萎缩性侧索硬化症动物研究的方法标准、报告质量和法规遵从性:系统综述。

Q1 Medicine BMJ Open Science Pub Date : 2019-08-01 eCollection Date: 2019-01-01 DOI:10.1136/bmjos-2018-000016
Joana G Fernandes, Nuno H Franco, Andrew J Grierson, Jan Hultgren, Andrew J W Furley, I Anna S Olsson
{"title":"肌萎缩性侧索硬化症动物研究的方法标准、报告质量和法规遵从性:系统综述。","authors":"Joana G Fernandes,&nbsp;Nuno H Franco,&nbsp;Andrew J Grierson,&nbsp;Jan Hultgren,&nbsp;Andrew J W Furley,&nbsp;I Anna S Olsson","doi":"10.1136/bmjos-2018-000016","DOIUrl":null,"url":null,"abstract":"<p><p></p><p><strong>Objectives: </strong>The amyotrophic lateral sclerosis (ALS) research community was one of the first to adopt methodology guidelines to improve preclinical research reproducibility. We here present the results of a systematic review to investigate how the standards in this field changed over the 10-year period during which the guidelines were first published (2007) and updated (2010).</p><p><strong>Methods: </strong>We searched for papers reporting ALS research on SOD1 (superoxide dismutase 1) mice published between 2005 and 2015 on the ISI Web of Science database, resulting in a sample of 569 papers to review, after triage. Two scores-one for methodological quality, one for regulatory compliance-were built from weighted sums of separate sets of items, and subjected to multivariable regression analysis, to assess how these related to publication year, type of study, country of origin and journal.</p><p><strong>Results: </strong>Reporting standards improved over time. Of papers published after the first ALS guidelines were made public, fewer than 9% referred specifically to these. Of key research parameters, only three (genetic background, number of transgenes and group size) were reported in >50% of the papers. Information on housing conditions, randomisation and blinding was absent in over two-thirds of the papers. Group size was among the best reported parameters, but the majority reported using fewer than the recommended sample size and only two studies clearly justified group size.</p><p><strong>Conclusions: </strong>General methodological standards improved gradually over a period of 8-10 years, but remained generally comparable with related fields with no specific guidelines, except with regard to severity. Only 11% of ALS studies were classified in the highest severity level (animals allowed to reach death or moribund stages), substantially below the proportion in studies of comparable neurodegenerative diseases such as Huntington's. The existence of field-specific guidelines, although a welcome indication of concern, seems insufficient to ensure adherence to high methodological standards. Other mechanisms may be required to improve methodological and welfare standards.</p>","PeriodicalId":9212,"journal":{"name":"BMJ Open Science","volume":"3 1","pages":"e000016"},"PeriodicalIF":0.0000,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715942/pdf/","citationCount":"3","resultStr":"{\"title\":\"Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review.\",\"authors\":\"Joana G Fernandes,&nbsp;Nuno H Franco,&nbsp;Andrew J Grierson,&nbsp;Jan Hultgren,&nbsp;Andrew J W Furley,&nbsp;I Anna S Olsson\",\"doi\":\"10.1136/bmjos-2018-000016\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p></p><p><strong>Objectives: </strong>The amyotrophic lateral sclerosis (ALS) research community was one of the first to adopt methodology guidelines to improve preclinical research reproducibility. We here present the results of a systematic review to investigate how the standards in this field changed over the 10-year period during which the guidelines were first published (2007) and updated (2010).</p><p><strong>Methods: </strong>We searched for papers reporting ALS research on SOD1 (superoxide dismutase 1) mice published between 2005 and 2015 on the ISI Web of Science database, resulting in a sample of 569 papers to review, after triage. Two scores-one for methodological quality, one for regulatory compliance-were built from weighted sums of separate sets of items, and subjected to multivariable regression analysis, to assess how these related to publication year, type of study, country of origin and journal.</p><p><strong>Results: </strong>Reporting standards improved over time. Of papers published after the first ALS guidelines were made public, fewer than 9% referred specifically to these. Of key research parameters, only three (genetic background, number of transgenes and group size) were reported in >50% of the papers. Information on housing conditions, randomisation and blinding was absent in over two-thirds of the papers. Group size was among the best reported parameters, but the majority reported using fewer than the recommended sample size and only two studies clearly justified group size.</p><p><strong>Conclusions: </strong>General methodological standards improved gradually over a period of 8-10 years, but remained generally comparable with related fields with no specific guidelines, except with regard to severity. Only 11% of ALS studies were classified in the highest severity level (animals allowed to reach death or moribund stages), substantially below the proportion in studies of comparable neurodegenerative diseases such as Huntington's. The existence of field-specific guidelines, although a welcome indication of concern, seems insufficient to ensure adherence to high methodological standards. Other mechanisms may be required to improve methodological and welfare standards.</p>\",\"PeriodicalId\":9212,\"journal\":{\"name\":\"BMJ Open Science\",\"volume\":\"3 1\",\"pages\":\"e000016\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715942/pdf/\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMJ Open Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/bmjos-2018-000016\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2019/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Open Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjos-2018-000016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 3

摘要

目的:肌萎缩性侧索硬化症(ALS)研究界是最早采用方法学指南来提高临床前研究可重复性的研究团体之一。我们在此提出了一项系统综述的结果,以调查该领域的标准在指南首次发布(2007年)和更新(2010年)的10年期间是如何变化的。方法:我们在ISI Web of Science数据库中检索2005年至2015年间发表的关于SOD1(超氧化物歧化酶1)小鼠ALS研究的论文,经分类后获得569篇论文。两个分数——一个是方法质量,一个是法规遵从性——是由独立项目集的加权和建立起来的,并经过多变量回归分析,以评估这些与出版年份、研究类型、原产国和期刊的关系。结果:报告标准随着时间的推移而提高。在第一份ALS指南公布后发表的论文中,只有不到9%的论文专门提到了这些。在关键的研究参数中,只有遗传背景、转基因数量和群体大小三个参数的报道占比大于50%。超过三分之二的论文缺少关于住房条件、随机化和盲法的信息。组大小是报告的最佳参数之一,但大多数报告使用的样本量少于推荐的样本量,只有两项研究明确证明了组大小的合理性。结论:一般的方法标准在8-10年间逐步改进,但除了严重程度外,与没有具体指南的相关领域总体上保持可比性。只有11%的ALS研究被归类为最高严重程度(允许动物达到死亡或垂死阶段),大大低于类似神经退行性疾病(如亨廷顿氏病)的研究比例。具体领域准则的存在虽然令人欢迎地表示关切,但似乎不足以确保遵守高方法标准。可能需要其他机制来改进方法和福利标准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review.

Objectives: The amyotrophic lateral sclerosis (ALS) research community was one of the first to adopt methodology guidelines to improve preclinical research reproducibility. We here present the results of a systematic review to investigate how the standards in this field changed over the 10-year period during which the guidelines were first published (2007) and updated (2010).

Methods: We searched for papers reporting ALS research on SOD1 (superoxide dismutase 1) mice published between 2005 and 2015 on the ISI Web of Science database, resulting in a sample of 569 papers to review, after triage. Two scores-one for methodological quality, one for regulatory compliance-were built from weighted sums of separate sets of items, and subjected to multivariable regression analysis, to assess how these related to publication year, type of study, country of origin and journal.

Results: Reporting standards improved over time. Of papers published after the first ALS guidelines were made public, fewer than 9% referred specifically to these. Of key research parameters, only three (genetic background, number of transgenes and group size) were reported in >50% of the papers. Information on housing conditions, randomisation and blinding was absent in over two-thirds of the papers. Group size was among the best reported parameters, but the majority reported using fewer than the recommended sample size and only two studies clearly justified group size.

Conclusions: General methodological standards improved gradually over a period of 8-10 years, but remained generally comparable with related fields with no specific guidelines, except with regard to severity. Only 11% of ALS studies were classified in the highest severity level (animals allowed to reach death or moribund stages), substantially below the proportion in studies of comparable neurodegenerative diseases such as Huntington's. The existence of field-specific guidelines, although a welcome indication of concern, seems insufficient to ensure adherence to high methodological standards. Other mechanisms may be required to improve methodological and welfare standards.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
BMJ Open Science
BMJ Open Science Medicine-General Medicine
CiteScore
10.00
自引率
0.00%
发文量
9
审稿时长
31 weeks
期刊最新文献
Correction: Preclinical safety study of nacre powder in an intraosseous sheep model. Protocol for a systematic review of the validity of animal models of polydipsia with a basis in schizophrenia aetiology. Preclinical safety study of nacre powder in an intraosseous sheep model. Protocol for a systematic review of good surgical practice guidelines for experimental rodent surgery. Genome-wide DNA methylation in an animal model and human studies of schizophrenia: a protocol for a meta-analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1